Abagovomab (Anti-MUC16) (A2396-GRP)

Abagovomab (Anti-MUC16) is a murine IgG1 monoclonal anti-idiotype antibody containing a variable antigen-binding region that functionally mimics the three-dimensional structure of a specific epitope on the ovarian cancer tumor-associated antigen CA-125 with potential antineoplastic activity. MW: 145.5 kD.